Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News AstraZeneca to present new clinical data at ERS 2016

AstraZeneca to present new clinical data at ERS 2016

31st August 2016

AstraZeneca will be sharing new clinical data at the European Respiratory Society (ERS) International Congress, which runs from September 3rd to 7th in London.

A total of 38 abstracts from the company have been accepted for presentation at the congress, including nine oral presentations focused on unmet medical needs in asthma and chronic obstructive pulmonary disease (COPD).

Key highlights will include the discussion of full phase III data for benralizumab, AstraZeneca's first respiratory biologic, as well as new evidence supporting dual bronchodilation methods in COPD and for Symbicort in both COPD and asthma.

Featured products include Duaklir and Bevespi Aerosphere, with results to be presented from the pivotal phase III trials SIROCCO and CALIMA.

Sean Bohen, executive vice-president of global medicines development and chief medical officer at AstraZeneca, said: "The data presented at ERS reflect the breadth of our scientific research in chronic respiratory disease and our progress in delivering the next generation of respiratory therapies."

Respiratory disease is one of AstraZeneca's main therapy areas, with its portfolio of medicines in this field reaching more than 17 million patients in 2015.

With? ?over? ?20? ?years? ?of? ?experience? ?within? ?the? ?pharmaceutical? ?market,? ?we? ?at? ?Zenopa? ?have? ?the knowledge,? ?skills? ?and? ?expertise? ?to? ?help? ?find? ?the? ?right? ?job? ?for? ?you.? ?To? ?find? ?out? ?more? ?about? ?the current? ?pharmaceutical? ?roles? ?we? ?have? ?available,? ?you? ?can? ?search? ?for? ?the? ?latest? ?job? ?roles, register? ?your? ?details,? ?or? ?contact? ?the? ?team? ?today.ADNFCR-8000103-ID-801824512-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.